Raya Therapeutic
QC - MontrealBiotechnology
Focus: Raya Therapeutic is a Montreal-based biotechnology company focused on developing compounds for amyotrophic lateral sclerosis (ALS), a severe neurodegenerative disorder. The company operates as a pre-revenue or early-stage biotech with a specialized focus on neurology.
Profile data last refreshed 9h ago · AI intelligence enriched 1w ago
Open Jobs
7
Should You Work at Raya Therapeutic?
AI assessmentRaya Therapeutic is a mission-driven early-stage play for scientists passionate about ALS drug discovery, but career stability and advancement opportunities are unclear without visibility into funding and pipeline maturity.
Why Work Here
- Opportunity to contribute to rare disease treatment in ALS, a high-unmet-need therapeutic area with significant patient impact
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Raya Therapeutic
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.